- Gillett VJ, Myatt G, Zsoldos Z, Johnson AP
(1995) SPROUT, HIPPO and CAESA: tools
for de novo structure generation and estima-
tion of synthetic accessibility. Perspect Drug
Discov Des 3:34–50 - Eisen MB, Wiley DC, Karplus M, Hubbard
RE (1994) HOOK: a program for finding
novel molecular architectures that satisfy the
chemical and steric requirements of a macro-
molecule binding site. Proteins 19:199–221 - Bohacek RS, McMartin C (1994) Multiple
highly diverse structures complementary to
enzyme binding sites: results of extensive
application of ade novodesign method incor-
porating combinatorial growth. J Am Chem
Soc 116:5560–5571 - Glen RC, Payne AWR (1995) A genetic algo-
rithm for the automated generation of mole-
cules within constraints. J Comput Aided Mol
Des 9:181–202 - Clark DE, Frenkel D, Levy SA, Li J, Murray
CW, Robson B, Waszkowycz B, Westhead DR
(1995) PRO-LIGAND: an approach tode
novomolecular design. 1. Application to the
design of organic molecules. J Comput Aided
Mol Des 9:13–32 - Miranker A, Karplus M (1995) An automated
method for dynamic ligand design. Proteins
23:472–490 - DeWitte RS, Shakhnovich EI (1996) SMoG
de novodesign method based on simple, fast,
and accurate free energy estimates. 1. Method-
ology and supporting evidence. J Am Chem
Soc 118:11733–11744 - Pearlman DA, Murcko MA (1996) CON-
CERTS: dynamic connection of fragments as
an approach tode novoligand design. J Med
Chem 39:1651–1663 - Luo Z, Wang R, Lai L (1996) RASSE: a new
method for structure-based drug design. J
Chem Inf Comput Sci 36:1187–1194 - Murray CW, Clark DE, Auton TR, Firth MA,
Li J, Sykes RA, Waszkowycz B, Westhead DR,
Young SC (1997) PRO_SELECT: combining
structure-based drug design and combinato-
rial chemistry for rapid lead discovery. 1. Tech-
nology. J Comput Aided Mol Des
11:193–207 - Todorov NP, Dean PM (1997) Evaluation of
a method for controlling molecular scaffold
diversity inde novoligand design. J Comput
Aided Mol Des 11:175–192 - Nachbar RB (2000) Molecular evolution:
automated manipulation of hierarchical
chemical topology and its application to aver-
age molecular structures. Genet Program
Evolvable Mach 1:57–94
57. Globus A, Lawton J, Wipke WT (1999) Auto-
matic molecular design using evolutionary
algorithms. Nanotechnology 10:290–299
58. Liu H, Duan Z, Luo Q, Shi Y (1999) Struc-
ture based ligand design by dynamically
assembling molecular building blocks at bind-
ing site. Proteins 36:462–470
59. Douguet D, Thoreau E, Grassy G (2000) A
genetic algorithm for the automated genera-
tion of small organic molecules: drug design
using an evolutionary algorithm. J Comput
Aided Mol Des 14:449–466
60. Wang R, Gao Y, Lai L (2000) LigBuilder: a
multi-purpose program for structure-based
drug design. J Mol Model 6:498–516
61. Schneider G, Lee ML, Stahl M, Schneider P
(2000)De novodesign of molecular architec-
tures by evolutionary assembly of drug-
derived building blocks. J Comput Aided
Mol Des 14:487–494
62. Zhu J, Fan H, Liu H, Shi Y (2001) Structure
based ligand design for flexible proteins:
application of new F-Dyco block. J Comput
Aided Mol Des 15:979–996
63. Pegg SCH, Haresco JJ, Kuntz ID (2001) A
genetic algorithm for structure-basedde novo
design. J Comput Aided Mol Des
15:911–933
64. Pellegrini E, Field MJ (2003) Development
and testing of ade novodrug-design algo-
rithm. J Comput Aided Mol Des 17:621–641
65. Vinkers HM, de Jonge MR, Daeyaert FF,
Heeres J, Koymans LM, van Lenthe JH,
Lewi PJ, Timmerman H, Van Aken K, Janssen
PA (2003) SYNOPSIS: SYNthesize and OPti-
mize system in silico. J Med Chem
46:2765–2773
66. Brown N, McKay B, Gilardoni F, Gasteiger J
(2004) A graph-based genetic algorithm and
its application to the multi objective evolution
of median molecules. J Chem Inf Comput Sci
44:1079–1087
67. Nikitin S, Zaitseva N, Demina O, Solovieva V,
Mazin E, Mikhalev S, Smolov M, Rubinov A,
Vlasov P, Lepikhin D, Khachko D, Fokin V,
Queen C, Zosimov V (2005) A very large
diversity space of synthetically accessible com-
pounds for use with drug design programs. J
Comput Aided Mol Des 19:47–63
68. Douguet D, Munier-Lehmann H, Labesse G,
Pochet S (2005) LEA3D: a computer-aided
ligand design for structure-based drug design.
J Med Chem 48:2457–2468
69. Fechner U, Schneider G (2006) Flux (1): a
virtual synthesis scheme for fragment basedde
novodesign. J Chem Inf Model 46:699–707
84 Venkatesan Suryanarayanan et al.